Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Palmitoleate-rich oil is a dietary supplement containing a high concentration of palmitoleic acid (omega-7), a monounsaturated fatty acid that occurs naturally in certain fish, macadamia nuts, and sea buckthorn. This oil is being investigated for its potential health benefits, particularly for **cardiovascular health**, **metabolic regulation**, and **anti-inflammatory properties**. Research indicates that palmitoleic acid acts as a **lipokine** (hormone-like fat) that can positively affect metabolism and reduce inflammation. Studies show it may help reduce atherosclerotic plaque formation, lower triglyceride levels, improve insulin sensitivity, and support healthy inflammatory responses[1][3][6]. The oil is currently being studied in clinical trials at the National Institutes of Health to further understand its effects on lipoprotein metabolism and cardiovascular health[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Palmitoleate-rich oil.